Impact of Green Tea Catechin Ingestion on the Pharmacokinetics of Lisinopril in Healthy Volunteers

Lisinopril, a highly hydrophilic long‐acting angiotensin‐converting enzyme inhibitor, is frequently prescribed for the treatment of hypertension and congestive heart failure. Green tea consumption may reduce the risk of cardiovascular outcomes and total mortality, whereas green tea or its catechin c...

Full description

Saved in:
Bibliographic Details
Main Authors: Shingen Misaka (Author), Yuko Ono (Author), Atsushi Uchida (Author), Tomoyuki Ono (Author), Osamu Abe (Author), Hiroshi Ogata (Author), Hideyuki Sato (Author), Masahiko Suzuki (Author), Satomi Onoue (Author), Yayoi Shikama (Author), Kenju Shimomura (Author)
Format: Book
Published: Wiley, 2021-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8ffee0fc0dfb4bab84c1da2a2c3ecaa5
042 |a dc 
100 1 0 |a Shingen Misaka  |e author 
700 1 0 |a Yuko Ono  |e author 
700 1 0 |a Atsushi Uchida  |e author 
700 1 0 |a Tomoyuki Ono  |e author 
700 1 0 |a Osamu Abe  |e author 
700 1 0 |a Hiroshi Ogata  |e author 
700 1 0 |a Hideyuki Sato  |e author 
700 1 0 |a Masahiko Suzuki  |e author 
700 1 0 |a Satomi Onoue  |e author 
700 1 0 |a Yayoi Shikama  |e author 
700 1 0 |a Kenju Shimomura  |e author 
245 0 0 |a Impact of Green Tea Catechin Ingestion on the Pharmacokinetics of Lisinopril in Healthy Volunteers 
260 |b Wiley,   |c 2021-03-01T00:00:00Z. 
500 |a 1752-8062 
500 |a 1752-8054 
500 |a 10.1111/cts.12905 
520 |a Lisinopril, a highly hydrophilic long‐acting angiotensin‐converting enzyme inhibitor, is frequently prescribed for the treatment of hypertension and congestive heart failure. Green tea consumption may reduce the risk of cardiovascular outcomes and total mortality, whereas green tea or its catechin components has been reported to decrease plasma concentrations of a hydrophilic β blocker, nadolol, in humans. The aim of this study was to evaluate possible effects of green tea extract (GTE) on the lisinopril pharmacokinetics. In an open‐label, randomized, single‐center, 2‐phase crossover study, 10 healthy subjects ingested 200 mL of an aqueous solution of GTE containing ~ 300 mg of (-)‐epigallocatechin gallate, a major catechin component in green tea, or water (control) when receiving 10 mg of lisinopril after overnight fasting. The geometric mean ratio (GTE/control) for maximum plasma concentration and the area under the plasma concentration‐time curve of lisinopril were 0.289 (90% confidence interval (CI) 0.226-0.352) and 0.337 (90% CI 0.269-0.405), respectively. In contrast, there were no significant differences in time to reach maximum lisinopril concentration (6 hours in both phases) and renal clearance of lisinopril (57.7 mL/minute in control vs. 56.9 mL/minute in GTE). These results suggest that the extent of intestinal absorption of lisinopril was significantly impaired in the presence of GTE, whereas it had no major effect on the absorption rate and renal excretion of lisinopril. Concomitant use of lisinopril and green tea may decrease oral exposure to lisinopril, and therefore result in reduced therapeutic efficacy. 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Clinical and Translational Science, Vol 14, Iss 2, Pp 476-480 (2021) 
787 0 |n https://doi.org/10.1111/cts.12905 
787 0 |n https://doaj.org/toc/1752-8054 
787 0 |n https://doaj.org/toc/1752-8062 
856 4 1 |u https://doaj.org/article/8ffee0fc0dfb4bab84c1da2a2c3ecaa5  |z Connect to this object online.